Clinical evaluation of Moorvadi Agad and Kalingadi Nasya in the management of Smoking induced Tamaka Shwasa
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To assess the efficacy of Moorvadi Agad & Kalingadi Nasya in the management of smoking induced Tamaka Shwasa. The primary objective of the study is reducing objective criteria like Dyspnea, Constant Coughing, Comfort in sitting position Wheezing sound, Difficulty in speech, Comfort when sputum is expectorated, Common cold, Insomnia, Sweating on forehead, Discomfort in lying down position Unconsciousness, Dry mouth
研究概览
简要总结
This study is single arm, an open label trial, with single group of 30 patients to assess the efficacy of Moorvadi Agad and Kalingadi Nasya in the management of smoking induced Tamaka Shwasa. The primary objective of the study is reducing subjective criteria like Dyspnea, Constant Coughing, Comfort in sitting position Wheezing sound, Difficulty in speech, Comfort when sputum is expectorated, Common cold, Insomnia, Sweating on forehead, Discomfort in lying down position Unconsciousness, Dry mouth. Moorvadi Agad will be administered with lukewarm water after meal in the dosage of 4gm orally thrice a day. Kalingadi Nasya will be administered in the form of nasal drops 1tsp powder form is soaked in lukewarm for one hour and squeeze out liquid through cloth in the dosage of 2-2 drops in each nostril twice a day.Total duration of the treatment is 30 days followed up once in a week regularly.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •a) Patient fulfilling the following general and diagnostic criteria was selected for the present study.
- •b) Patients diagnosed as Tamaka Shwasa based on clinical features mentioned in Ayurvedic texts.
- •c) Sex- either sex d) Patients who are between 20-60 years will be selected.
- •e) Patient willing to sign the consent form.
- •f) Patient should be capable of obeying Pathya-apathya.
排除标准
- •a) Bronchial Carcinoma b) COPD c) Emphysema d) Pleural Effusion e) Tuberculosis Other Endocrine disorders like Diabetes, Thyroid dysfunction.
结局指标
主要结局
To assess the efficacy of Moorvadi Agad & Kalingadi Nasya in the management of smoking induced Tamaka Shwasa. The primary objective of the study is reducing objective criteria like Dyspnea, Constant Coughing, Comfort in sitting position Wheezing sound, Difficulty in speech, Comfort when sputum is expectorated, Common cold, Insomnia, Sweating on forehead, Discomfort in lying down position Unconsciousness, Dry mouth
时间窗: 30Days
次要结局
- Improve quality of life(30 days)